TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bioform AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
23,331
|
20,994
|
12,530 |
| Financial expenses |
233
|
135
|
138 |
| Earnings before taxes |
9,089
|
8,553
|
802 |
| Total assets |
31,628
|
20,388
|
17,422 |
| Current assets |
23,909
|
16,893
|
14,927 |
| Current liabilities |
4,771
|
2,033
|
5,182 |
| Equity capital |
24,918
|
18,356
|
12,241 |
| - share capital |
679
|
691
|
740 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.8%
|
90.0%
|
70.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
39.0%
|
40.7%
|
6.4% |
| Return on assets (ROA) |
29.5%
|
42.6%
|
5.4% |
| Current ratio |
501.1%
|
830.9%
|
288.1% |
| Return on equity (ROE) |
36.5%
|
46.6%
|
6.6% |
| Change turnover |
2,708
|
9,295
|
-2,974 |
| Change turnover % |
13%
|
79%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.